SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-20-000634
Filing Date
2020-04-01
Accepted
2020-04-01 16:20:52
Documents
2
Period of Report
2020-03-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1569
2 EXHIBIT 24 - POWER OF ATTORNEY nicholson.htm EX-24 6987
  Complete submission text file 0001123292-20-000634.txt   9925
Mailing Address C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Business Address
Nicholson Garry A (Reporting) CIK: 0001640861 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38905 | Film No.: 20765667

Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Issuer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences